En Es
Categories

Industry News

Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing

By Labmedica International staff writers
14 Jun 2022

Image: Sofia 2 Lyme FIA is the only FDA-approved rapid POC test on the market (Photo courtesy of Quidel)

Lyme disease is a growing epidemic and more than 14% of the world’s population probably has, or has had, the tick-borne disease, as indicated by the presence of antibodies in the blood. Borrelia burgdorferi sensu lato (Bb) infection, more usually known as Lyme disease, is the most common type of tick-borne infection, with ticks second only to mosquitoes in terms of their carriage of harmful microbes. Redness and swelling at the site of the tick bite is typical, but the infecting agent can spread to other tissues and organs, potentially affecting the nervous system, joints, heart and skin. Lyme disease has continued to spread around the world, but there’s no agreement on just how common it is globally, or what the specific risk factors might be.


Now, Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond. Quidel is the leading developer in the US of the only FDA-approved rapid point of care diagnostic Lyme disease test. As part of its partnership, Quidel serves as GLA’s Official Sponsor during Lyme Awareness Month and will partner on a series of educational PACE accredited webinars. The webinars will provide new information on various Lyme topics in an open discussion format, all designed to bring awareness to Lyme disease, along with rapid ways to diagnose Lyme, leading to prompt treatment.


Leading the way in Lyme disease testing is Quidel’s Sofia 2 Lyme FIA. The only FDA-approved rapid point of care test on the market provides the patient and their physician with indicative results within 15 minutes instead of days, which has historically been the norm. Performed in the privacy of a doctor’s office or local clinic, it is also the only test that can get results from a simple finger prick of blood.


Related Links:
Quidel Corporation 
Global Lyme Alliance 



E-mail Print
FaceBook Twitter Google+ Linked in

QUIDEL

Develops, manufactures and markets rapid diagnostic tests at the point-ofcare (POC) that focus on infectious diseases and reproductive health
More info

More articles about QUIDEL

24 Dec 2021
Quidel Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
Quidel Corporation (San Diego, CA, USA) and Ortho Clinical Diagnostics (Raritan, NJ, USA) have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies.
Read More
15 Jun 2021
Quidel Receives Amended FDA Emergency Use Authorization for New AI-Powered Sofia Q Rapid Antigen Test Device
Quidel Corporation (San Diego, CA, USA) has received an amended Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) allowing the company to market Sofia Q, its latest addition to the Sofia and Sofia 2 line of Fluorescent Immunoassay Analyzers (FIA).
Read More
24 Jul 2017
Quidel to Acquire Alere Triage Assets
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has entered into definitive agreements to acquire the Triage MeterPro cardiovascular (CV) and toxicology assets (“Triage business”) and the B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”) from Alere Inc. These products are being divested in order to obtain antitrust approvals required for Abbott’s pending acquisition of Alere.
Read More

Additional news

05 Aug 2022
Bio-Rad Acquires Curiosity Diagnostics from Scope Fluidics
Bio-Rad Laboratories (Hercules, CA, USA) has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (Warsaw, Poland) for a total consideration of up to USD 170 million, consisting of approximately USD 100 million in cash, and up to USD 70 million in future milestone payments.
Read More
04 Aug 2022
Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure
The global capsule endoscopy system market is expanding at a rapid pace due to the rising demand for the procedure using minimally invasive diagnostic techniques, increase in the introduction of technologically advanced capsules, growth in the geriatric population, and rising prevalence of cancer around the world.
Read More
02 Aug 2022
PerkinElmer Divests Other Businesses to Focus on Life Sciences and Diagnostics
PerkinElmer, Inc. (Waltham, MA; USA) has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital (New York, NY, USA) for total consideration of USD 2.45 billion in cash.
Read More
31 Jul 2022
Labcorp to Spin Off Clinical Development Business
LabCorp Diagnostics (Burlington, NC, USA) has announced that its board of directors has authorized the company to pursue a spin-off of its wholly owned Clinical Development business to shareholders through a tax-free transaction.
Read More
31 Jul 2022
IFCC Celebrates 70 Years of Advancing Science of Laboratory Medicine and In Vitro Diagnostics
The IFCC is celebrating 70 years (1952 – 2022) of enormous achievements that have been extraordinary and impressive, contributing to its mission of “Advancing excellence in laboratory medicine for better healthcare worldwide”.
Read More
27 Jul 2022
Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand
Informa Markets (London, UK), in partnership with Impact Muang Thong Thani (Nonthaburi, Thailand), have confirmed that Medlab Asia and Asia Health will take place in Thailand for the first time when the co-located events return live and in-person at the Impact Exhibition Center, Bangkok, from 19-21 October 2022.
Read More
25 Jul 2022
Registration Opens for RSNA 2022
Registration is now open for the Radiological Society of North America’s (RSNA, Oak Brook, IL, USA) 108th Scientific Assembly and Annual Meeting to be held at McCormick Place Chicago, Nov. 27 – Dec. 1, 2022.
Read More
25 Jul 2022
Bioperfectus and ELITechGroup Collaborate for Monkeypox Virus Testing Across Europe
Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) and ELITechGroup S.p.A. (Puteaux, France) have entered into a strategic partnership for monkeypox virus testing across Europe.
Read More
20 Jul 2022
GE's Healthcare Business to Be Named GE HealthCare
GE (Boston, MA, USA) has announced that GE HealthCare will be the name of its healthcare business following its planned separation into three industry-leading, global, investment-grade public companies.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions